Japan’s IVD sector remains highly structured and closely governed, benefiting from a mature healthcare infrastructure and […]
Overview: Introduction Six-month review process priority registration expanded PMDA support innovative drug consultation early application feedback […]
A Thriving Landscape in Japan’s Pharma Sector Pharma Japan and Strategic Opportunities are plentiful in Japan. […]